ストックスクリーナーアプリを入手
5.39
1.11%
-0.02
前日終値:
$5.41
開ける：
$5.41
24時間の取引高:
74,944
Relative Volume:
0.34
時価総額：
$195.62M
収益：
$8.98M
当期純損益:
$-31.39M
株価収益率:
-4.0224
EPS:
-1.34
ネットキャッシュフロー:
$-24.83M
1週間 パフォーマンス:
-28.48%
1か月 パフォーマンス:
-16.93%
6か月 パフォーマンス:
+35.10%
1年 パフォーマンス:
-21.55%
1日の値動き範囲:
$5.24
$5.61
1週間の範囲:
$4.80
$7.59
52週間の値動き範囲:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
名前
Profound Medical Corp
セクター
電話
647-476-1350
住所
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.39 | 196.34M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
110.21 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.37 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.00 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.86 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.64 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-07-23 | 開始されました | Lake Street | Buy |
| 2024-07-16 | アップグレード | Stifel | Hold → Buy |
| 2023-11-28 | 開始されました | Stifel | Hold |
| 2023-08-04 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-03-21 | ダウングレード | Jefferies | Buy → Hold |
| 2020-09-15 | 開始されました | Jefferies | Buy |
すべてを表示
Profound Medical Corp (PROF) 最新ニュース
(PRN) Comprehensive Trading Strategy Report (PRN:CA) - Stock Traders Daily
Profound Medical Announces Board Resignation and New Appointment - TipRanks
Profound Medical to Host Investor Call to Discuss First Clinical Outcomes from the CAPTAIN Trial on March 13; Participate in ROTH Investor Conference on March 22-24 - Investing News Network
Profound Medical to Host Investor Call March 13 on First CAPTAIN Trial Outcomes Presented at EAU 2026 - TradingView
Profound Medical (PROF) Awaits Key Clinical Data Presentation - GuruFocus
Profound Medical to Present First CAPTAIN Trial Results and Steps Up Investor Outreach - TipRanks
(PRN) Technical Pivots with Risk Controls (PRN:CA) - Stock Traders Daily
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript - Insider Monkey
Profound Medical (TSX:PRN) Narrowing EPS Loss In Q3 2025 Tests Growth Optimism Narrative - simplywall.st
History Review: Can Profound Medical Corp beat the S P 500Market Volume Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
Street Watch: Is OVBC forming a bullish divergenceEarnings Performance Report & Verified Swing Trading Watchlist - baoquankhu1.vn
Profound Medical (TSE:PRN) Trading Down 26%Time to Sell? - MarketBeat
Profound Medical (NASDAQ:PROF) Issues Earnings Results - MarketBeat
Profound Medical reports net loss of USD 8.2M in Q4 2025 - Medical Buyer
Profound Medical Corp (PROF) Q4 2025 Earnings Call Highlights: R - GuruFocus
Profound Medical Posts Record Q4 Revenue as TULSA-PRO Adoption and Global Expansion Accelerate - The Globe and Mail
Profound Medical Q4 Earnings Call Highlights - Yahoo Finance
Aug Sentiment: Can Profound Medical Corp beat the S P 500July 2025 Weekly Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Earnings call transcript: Profound Medical Q4 2025 EPS surprises, stock rises - Investing.com South Africa
Profound Medical (PROF) Reports Q4 Revenue Below Expectations - GuruFocus
Profound Medical (PROF) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
Profound Medical Q4 Earnings Assessment - Benzinga
Profound Medical Corp. Q4 Profit Climbs - Nasdaq
Profound Medical Brief: Reports Q4 Revenue of US$6.0 Mln, Up From US$4.2 Mln a Year Earlier - marketscreener.com
Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Profound Medical Brief: Reports a Fourth-Quarter Loss of US$8.2 Mln, or US$0.27 per Share, Compared To a Loss of US$4.9 Mln, or US$0.20 in the Year-Prior Quarter - marketscreener.com
Profound Medical Corp. Announces Board Changes, Effective March 5, 2026 - marketscreener.com
Profound Medical $PROF Shares Purchased by First Eagle Investment Management LLC - MarketBeat
Profound Medical's Earnings: A Preview - Benzinga
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: Wh - GuruFocus
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline - Finviz
Profound Medical (PROF) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Risk Hedge: What is the Moat Score of NYXHEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tech Rally: What hedge funds are buying Profound Medical CorpPortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Energy Moves: Can Affimed NV outperform under higher oil pricesInsider Selling & Weekly Consistent Profit Watchlists - baoquankhu1.vn
(PRN) Risk-Controlled Trading Report (PRN:CA) - Stock Traders Daily
Certain stock options of Profound Medical Corp. are subject to a Lock-Up Agreement Ending on 22-FEB-2026. - marketscreener.com
Is Profound Medical Corp. trading at a discountPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
Profound Medical (TSE:PRN) Stock Price Up 2.6%What's Next? - MarketBeat
Profound Medical launches up to $40 million equity financing to support growth - MSN
(PRN) Strategic Market Analysis (PRN:CA) - Stock Traders Daily
Buy Signal: How does Profound Medical Corp perform in inflationary periods2025 Performance Recap & Community Driven Trade Alerts - baoquankhu1.vn
What margin trends mean for Profound Medical Corp. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
(PRN) Strategic Investment Guide (PRN:CA) - Stock Traders Daily
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow - marketscreener.com
Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27% - simplywall.st
Profound Medical Schedules Q4 and 2025 Results Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow - marketscreener.com
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease - Investing News Network
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion - TipRanks
Profound Medical Corp (PROF) 財務データ
収益
当期純利益
現金流量
EPS
1.61%
1.47%
大文字化:
|
ボリューム (24 時間):